Companies /Healthcare

Rocket Pharmaceuticals Inc

NASDAQ: RCKT Biotechnology
$2.15
▲ $0.04 (+1.90%) today
Markets open · 10:08am ET

RCKT at a Glance

Valuation
Market cap
$235.6M
Profitability
EPS (TTM)
$-0.15
Price
52-week range
$2 – $5
Street target
$8.82

Headquartered in Cranbury, NJ Fiscal year ends December NASDAQ: RCKT rocketpharma.com

About Rocket Pharmaceuticals

Rocket Pharmaceuticals is a commercial-stage biotechnology company developing genetic medicines for rare and life-threatening diseases. Its strategic focus is inherited cardiovascular disorders, and it also has programs in hematology and immunology.

Its cardiovascular portfolio includes three clinical-stage AAV gene therapy programs:
- RP-A501 for Danon disease, a hypertrophic cardiomyopathy, now in a pivotal Phase 2 trial.
- RP-A601 for PKP2 arrhythmogenic cardiomyopathy, in Phase 1.
- RP-A701 for BAG3-associated dilated cardiomyopathy, in Phase 1.

The company has proprietary AAV manufacturing capabilities and clinical experience in cardiac gene therapy.

Its first commercial product is KRESLADI (marnetegragene autotemcel). It is an autologous, lentiviral-vector hematopoietic stem cell gene therapy for severe leukocyte adhesion deficiency-I (LAD-I), approved under accelerated approval. KRESLADI reached commercial readiness on October 1, 2026, with two Qualified Treatment Centers activated and an external manufacturing network in place.

The company funds development through cash and investments, proceeds from a priority review voucher sale, and a credit facility of up to $150 million with Hercules Capital. Updated

RCKT Coverage

Frequently Asked Questions

What does Rocket Pharmaceuticals do?

Rocket Pharmaceuticals is a commercial-stage biotechnology company developing genetic medicines for rare and life-threatening diseases. Its strategic focus is inherited cardiovascular disorders, and it also has programs in hematology and immunology.

What is the RCKT stock price target?

The Wall Street consensus 12-month price target for RCKT is $8.82.